Assessing the Potential Patient Care Implications of New Data in Eosinophilic Esophagitis: Clinical Transfers®

Program Overview

In this activity, 2 experts in the diagnosis and management of eosinophilic esophagitis (EoE) analyze data on the treatment of this disease that was presented at the 2021 Digestive Disease Week virtual meeting. Topics for discussion include updates on current management approaches for EoE, new research highlighting the pathophysiological underpinnings of EoE, and late-breaking data on emerging treatment approaches for individuals with EoE.

Credit Expired

Target Audience

Gastroenterologists, pediatric gastroenterologists, allergy/immunologists, pediatric allergy/immunologists, and other healthcare professionals involved in the treatment of patients with eosinophilic esophagitis (EoE).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Assess recently presented data on current approaches for the management of eosinophilic esophagitis (EoE)
Summarize new findings related to immune pathophysiologic pathways and therapeutic targets for EoE
Analyze late-breaking data related to the efficacy, safety, and tolerability of new and emerging therapies for treatment of EoE

Activity Faculty

Evan S. Dellon, MD, MPH (Chair)

Professor, Medicine
Adjunct Professor, Epidemiology
University of North Carolina School of Medicine
Chapel Hill, NC

Amanda B. Muir, MD, MTR

Attending Physician
Children’s Hospital of Philadelphia, Research Institute
Philadelphia, PA

Featured RMEI CE Activities – Earn CE Credit(s)

Assessing the Potential Patient Care Implications of New Data in Eosinophilic Esophagitis: Clinical Transfers®

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Evan S. Dellon, MD, MPH (Chair)

Amanda B. Muir, MD, MTR

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care: A Care Team Forum®

Refining Management of CMV After Transplant: Exploiting Recent Advances to Alleviate Patient Burden

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

Subscribe